Acute Intravenous Acyl Ghrelin Infusion Induces Thirst but Does Not Affect Sodium Excretion - Two Randomized, Double Blind, Placebo Controlled Crossover Studies in Hypopituitary Patients

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

DOI

Objective Acyl ghrelin, which is the endogenous ligand for the growth hormone secretagogue receptor, potently stimulates pituitary growth hormone release, and to some degree adrenocorticotropic hormone and prolactin. Ghrelin is also orexigenic and has recently been shown to stimulate renal sodium absorption in rodent models. Increased thirst sensation has been observed as a side effect of acyl ghrelin administration in some human studies. The objective of this clinical trial was to investigate the direct effects of acyl ghrelin on thirst sensation and sodium excretion in hypopituitary patients. Design Hypopituitary patients on stable replacement with hydrocortisone and growth hormone were investigated in two double blind and placebo controlled crossover studies. The patients received a 5-h intravenous infusion of acyl ghrelin (5 pmol/kg/min in the first study and 1 pmol/kg/min in the second study). Thirst sensation was measured on a Visual Analogue Scale (VAS). In the second study plasma osmolality, vasopressin, copeptin, water intake, diuresis, and urinary excretion of sodium and creatinine were measured. Results In the initial study, acyl ghrelin (5 pmol/kg/min) increased thirst sensation (time x treatment Analysis of Variance for the effect of acyl ghrelin infusion P = 0.003). In the second study acyl ghrelin (1 pmol/kg/min) also increased thirst (P = 0.04) but did not affect urinary excretion of either sodium or water. Conclusions We demonstrate that acyl ghrelin infusion increases thirst sensation, without affecting sodium excretion or diuresis in human subjects.

Original languageEnglish
JournalEuropean Journal of Endocrinology
Volume181
Issue1
Pages (from-to)23-30
Number of pages8
ISSN0804-4635
DOIs
Publication statusPublished - 2019

    Research areas

  • HUMAN GROWTH-HORMONE, NATRIURESIS, NEUROPEPTIDE-Y, RELEASE, VASOPRESSIN, Creatinine/urine, Double-Blind Method, Thirst/drug effects, Humans, Middle Aged, Hydrocortisone/therapeutic use, Drinking, Ghrelin/administration & dosage, Male, Hypopituitarism/drug therapy, Cross-Over Studies, Glycopeptides/blood, Natriuresis/drug effects, Osmolar Concentration, Arginine Vasopressin/blood, Placebos, Infusions, Intravenous, Growth Hormone/therapeutic use

See relations at Aarhus University Citationformats

ID: 153021367